炎症性关节炎患者治疗黑色素瘤免疫检查点抑制剂的生存率较差

H B Tenstad1, C H Ruhlmann2, S Möller3

  • 1Section of Rheumatology, Department of Internal Medicine, Odense University Hospital Svendborg, Denmark; Department of Rheumatology, Odense University Hospital, Denmark; Department of Clinical Research, University of Southern Denmark, Denmark.

PubMed
概括

接受黑色素瘤免疫检查点抑制剂 (ICI) 的炎症性关节炎患者的生存结果更差. 基线免疫抑制可能有助于,强调需要多学科护理,以改善这些患者的存活率.